SHAREHOLDER ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit Against Globus Medical, Inc. and Encourages Investors to Contact the Firm

Loading...
Loading...
IRVINE, Calif.--(BUSINESS WIRE)--

Khang & Khang LLP (the "Firm") announces that a class action lawsuit has been filed against Globus Medical, Inc. ("Globus" or the "Company") GMED. Investors who purchased or otherwise acquired shares between February 26, 2015 and August 5, 2015, inclusive (the "Class Period") are encouraged to contact the Firm immediately to discuss their legal options.

If you purchased shares of Globus during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by email at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

According to the complaint, the Company made misleading statements and/or failed to disclose that: (1) the Company's relationship with an important distributor was deteriorating; and (2) that this deterioration was hurting the Company's financial performance. When the truth was revealed, shares dropped causing investors harm.

If you purchased shares of Globus during the Class Period you have until November 30, 2015 to ask the Court to appoint you as lead plaintiff. If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by email at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

KHANG & KHANG LLP
Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...